(TSX-V:SLI),(Boerse Frankfurt – Freiverkehr:S5L),(NYSE MKT:SLI), VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) — Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE.A: SLI), a leading near-commercial lithium company, will have senior leadership participating in multiple upcoming investor conferences. The Company will be participating in the virtual Deutsche Bank Lithium and Battery Supply […]

CALGARY, Alberta, Nov. 18, 2025 (GLOBE NEWSWIRE) — Mawer Investment Management Ltd. (“Mawer”) is honoured to be recognized once again as one of Canada's Top 100 Employers for 2026. This national award reflects Mawer's ongoing commitment to fostering a resilient, people-first workplace–one that adapts to change and invests in its employees, even amid a rapidly

(NASDAQ:DAWN), BRISBANE, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced that management will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare

SAN FRANCISCO, Nov. 18, 2025 (GLOBE NEWSWIRE) — Observe.AI, the leader in AI agents for customer experience, today announced it has been named a Gartner Cool Vendor in the “Gartner Cool Vendors in Customer Service and Support Technology” report. The emerging vendors highlighted in this research are transforming the market with innovative AI-first approaches that

(ASX – Trade24:RAD),(AUST:RAD.AX),(NASDAQ:RADX), RAD 402 is a humanized IgG1 internalized by prostate cells, binding KLK3 with high affinity Tb-161 antitumor activity driven by the dual emission of beta particles and Auger electrons SYDNEY, Nov. 18, 2025 (GLOBE NEWSWIRE) — Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology

Autonomix Medical, Inc. Announces Pricing of $5.0 Million Private Placement Priced At The Market Under Nasdaq Rules GlobeNewswire November 18, 2025 THE WOODLANDS, TX, Nov. 18, 2025 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that it has entered

Fennec Pharmaceuticals Announces Closing of Private Offering of Common Shares in Canada GlobeNewswire November 18, 2025 RESEARCH TRIANGLE PARK, N.C., Nov. 18, 2025 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced the closing of its non-brokered offering of its common shares in Canada, at a

Cuprina forms Joint Venture Company with Aiodine Laboratory to Develop and Market Novel Iodine-based Solution as New Wound Care Therapy GlobeNewswire November 18, 2025 SINGAPORE, Nov. 18, 2025 (GLOBE NEWSWIRE) — Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company“), a biomedical company developing and marketing products for the chronic wounds, infertility, and cosmeceuticals

Buy Event Tickets, Earn United Miles: Vivid Seats and United Airlines Team Up Vivid Seats customers and MileagePlus(R) members can earn miles for flights, upgrades, and more when purchasing tickets to live events around the world GlobeNewswire November 18, 2025 CHICAGO, Nov. 18, 2025 (GLOBE NEWSWIRE) — Vivid Seats Inc. (NASDAQ: SEAT) (“Vivid Seats” or

OKYO Pharma to Present at OIS XV in San Diego GlobeNewswire November 18, 2025 LONDON and NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular condition associated with chronic and often severe nerve-related pain but